Menu

Tenet Healthcare Corporation THC

Full chart Compare
Set alert

Price alert · THC

All alert types
283.33 USD -3.13 (-1.09%)

At closeNov 6, 2026, 6:47 PM EST

284.00 +0.67 +0.24%

After hours · Nov 6, 6:47 PM ET

276.87 Day range 285.76
157.58 52-week range 301.44
YTD
+42.58%
1 year
+38.76%
Market cap
22.55B
Revenue (ttm)
22.15B
Profit margin
13.09%
EPS (ttm)
34.29
Shares out
79.59M
P/E ratio
8.26
Forward P/E
13.85
YTD return
+42.58%
1-year return
+38.76%
Volume
631.60K
Avg volume
775.52K
Open
280.00
Previous close
286.46
Day's range
276.87 – 285.76
52-week range
157.58 – 301.44
Beta
1.20
Analysts
Buy
Price target
304.14 (+7.3%)
Earnings date
Feb 10, 2027

5D +10.28 (+3.76%)

260280300MonTueWedThuFri283.33

Key statistics

Enterprise value
37.52B
PEG ratio
2.12
Price / sales
1.02
Price / book
4.14
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
6.50%
Free cash flow
2.03B
Total cash
2.67B
Total debt
13.24B
Return on equity
41.70%
Short % of float
2.71%
50-day average
265.05
200-day average
221.87

Financials — quick view

All financials
THC Revenue — quarterly 6.28B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC Net income — quarterly 1.00B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC EPS — quarterly 12.48
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

THC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 10, 2027Dec 30, 20265.36———
Oct 29, 2026Sep 30, 20264.686.64+1.96+41.88%
Jul 22, 2026Jun 30, 20264.266.12+1.86+43.66%
Apr 30, 2026Mar 31, 20264.174.82+0.65+15.59%
Feb 11, 2026Dec 31, 20254.074.70+0.63+15.48%
Oct 28, 2025Sep 30, 20253.343.70+0.36+10.78%

Upgrades / downgrades

THC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 4, 2026BarclaysmainOverweightOverweight
Nov 3, 2026Truist SecuritiesreitBuyBuy
Nov 3, 2026KeybancmainOverweightOverweight
Nov 2, 2026Leerink PartnersmainOutperformOutperform
Nov 2, 2026RBC CapitalmainOutperformOutperform
Nov 2, 2026Wells FargomainOverweightOverweight

About Tenet Healthcare Corporation

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on THC — it syncs with the Stock Master app.

Insider holders

THC insider holders
InsiderRelationLatest transactionDateShares held
ARBOUR PAOLA MChief Technology OfficerSaleJul 26, 202618,413
BIERMAN JAMES LDirectorSaleJul 26, 202631,604
FISHER RICHARD W.DirectorConversion of Exercise of derivative securityMay 21, 20269,632
FITZGERALD MEGHANDirectorConversion of Exercise of derivative securityMay 21, 202617,087
HANEY CECIL D.DirectorStock GiftAug 27, 202612,403
MARK RICHARD JDirectorSaleSep 9, 202625,121

Institution ownership

THC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.99%8,743,0052.48BJun 29, 2026
Price (T.Rowe) Associates Inc10.00%7,957,4492.25BJun 29, 2026
Boston Partners5.57%4,433,3601.26BJun 29, 2026
Vanguard Portfolio Management LLC5.33%4,238,1081.20BJun 29, 2026
FMR, LLC5.02%3,994,5451.13BJun 29, 2026
Vanguard Capital Management LLC4.89%3,894,1891.10BJun 29, 2026

Fund ownership

THC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.60%2,868,116812.57MSep 29, 2026
TR PRICE-Price (T.Rowe) U.S. Value Equity Trust3.57%2,840,356804.70MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.44%2,734,962774.84MJun 29, 2026
T. Rowe Price Value Fund, Inc.2.63%2,092,106592.71MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.48%1,975,296559.62MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.75%1,394,363395.04MSep 29, 2026